Value of albumin dialysis therapy in severe liver insufficiency - PubMed
. 2005 Jan;17(11):717-23.
doi: 10.1007/s00147-004-0796-2. Epub 2004 Dec 3.
Affiliations
- PMID: 15580335
- DOI: 10.1007/s00147-004-0796-2
Free article
Value of albumin dialysis therapy in severe liver insufficiency
Arttu Lahdenperä et al. Transpl Int. 2005 Jan.
Free article
Abstract
A blood purification system, molecular adsorbents re-circulating system (MARS), is based on the removal of both protein-bound and water-soluble substances and toxins in the liver. We treated a total of 88 patients within 2 years. Of these patients, 45 had acute liver failure (ALF), 31 had acute decompensation of chronic liver disease, eight had graft failure and four had miscellaneous conditions. Of the patients with ALF, 80% survived; in 23 patients their own liver recovered and 13 patients underwent successful transplantation. Only 23% of patients with acute-on-chronic liver failure survived. Most of them were not considered for transplantation due to their having liver failure from alcoholism and from not abstaining from drinking. MARS is a promising therapy for ALF, allowing the patient's own liver to recover or allowing enough time to find a liver graft. Best results were achieved in patients who had been intoxicated with a lethal dose of toxin. On the other hand, we did not observe much benefit in patients with severe acute-on-chronic liver failure (AcoChr) who did not undergo liver transplantation.
Similar articles
-
Koivusalo AM, Vakkuri A, Höckerstedt K, Isoniemi H. Koivusalo AM, et al. Transplant Proc. 2005 Oct;37(8):3315-7. doi: 10.1016/j.transproceed.2005.09.007. Transplant Proc. 2005. PMID: 16298584
-
Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Höckerstedt K. Isoniemi H, et al. Transplant Proc. 2005 Mar;37(2):1088-90. doi: 10.1016/j.transproceed.2004.11.060. Transplant Proc. 2005. PMID: 15848631
-
Rusu EE, Voiculescu M, Zilisteanu DS, Ismail G. Rusu EE, et al. J Gastrointestin Liver Dis. 2009 Sep;18(3):311-6. J Gastrointestin Liver Dis. 2009. PMID: 19795025
-
Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G. Mitzner SR, et al. J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S75-82. J Am Soc Nephrol. 2001. PMID: 11251037 Review.
-
[Liver support systems today].
Rikker C. Rikker C. Orv Hetil. 2009 Dec 20;150(51):2299-307. doi: 10.1556/OH.2009.28769. Orv Hetil. 2009. PMID: 19995693 Review. Hungarian.
Cited by
-
Inderbitzin D, Muggli B, Ringger A, Beldi G, Gass M, Gloor B, Uehlinger D, Regli B, Reichen J, Candinas D. Inderbitzin D, et al. J Gastrointest Surg. 2005 Nov;9(8):1155-61; discussion 1161-2. doi: 10.1016/j.gassur.2005.07.026. J Gastrointest Surg. 2005. PMID: 16269387
-
Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.
Kantola T, Mäklin S, Koivusalo AM, Räsänen P, Rissanen A, Roine R, Sintonen H, Höckerstedt K, Isoniemi H. Kantola T, et al. World J Gastroenterol. 2010 May 14;16(18):2227-34. doi: 10.3748/wjg.v16.i18.2227. World J Gastroenterol. 2010. PMID: 20458759 Free PMC article.
-
Survival predictors in patients treated with a molecular adsorbent recirculating system.
Kantola T, Koivusalo AM, Parmanen S, Höckerstedt K, Isoniemi H. Kantola T, et al. World J Gastroenterol. 2009 Jun 28;15(24):3015-24. doi: 10.3748/wjg.15.3015. World J Gastroenterol. 2009. PMID: 19554655 Free PMC article.
-
Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy.
Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H. Koivusalo AM, et al. Metab Brain Dis. 2008 Dec;23(4):387-98. doi: 10.1007/s11011-008-9110-9. Epub 2008 Sep 5. Metab Brain Dis. 2008. PMID: 18773287 Clinical Trial.
-
Camus C, Lavoué S, Gacouin A, Le Tulzo Y, Lorho R, Boudjéma K, Jacquelinet C, Thomas R. Camus C, et al. Intensive Care Med. 2006 Nov;32(11):1817-25. doi: 10.1007/s00134-006-0340-1. Epub 2006 Aug 29. Intensive Care Med. 2006. PMID: 16941171
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous